2002
DOI: 10.1002/glia.10151
|View full text |Cite
|
Sign up to set email alerts
|

Role of p38 and p44/42 mitogen‐activated protein kinases in microglia

Abstract: Although microglial cells are thought to play a beneficial role in the regeneration and plasticity of the central nervous system (CNS), recent studies have indicated that at least some molecules released by microglia may be harmful in acute brain insults and neurodegenerative diseases. Therefore, the pathways mediating the synthesis and release of these neurotoxic compounds are of importance. p38 and p44/42 families of mitogen-activated protein kinases (MAPKs) in microglia respond strongly to various extracell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
194
0
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 260 publications
(202 citation statements)
references
References 109 publications
5
194
0
1
Order By: Relevance
“…Such activation of MAPK cascades is consistent with inflammatory activation of microglia [69]. Ibrahim and coworkers also used IHC staining with retinal microglia marker antibody and with an antibody to Almadori-glycated albumin (AGA) to show that both were localized in the ganglion cell layer [68].…”
Section: Microglial Activation In Diabetic Retinopathymentioning
confidence: 79%
“…Such activation of MAPK cascades is consistent with inflammatory activation of microglia [69]. Ibrahim and coworkers also used IHC staining with retinal microglia marker antibody and with an antibody to Almadori-glycated albumin (AGA) to show that both were localized in the ganglion cell layer [68].…”
Section: Microglial Activation In Diabetic Retinopathymentioning
confidence: 79%
“…In microglia, many proinflammatory stimuli cause phosphorylation (activation) of the mitogenactivated protein kinase p38 MAPK and consequent production of cytotoxic molecules, including nitric oxide (Jeohn et al, 2002;Koistinaho and Koistinaho, 2002). Similar p38 MAPK activation occurs in numerous acute and chronic brain disorders, including stroke, spinal cord injury, Alzheimer's disease, and Parkinson's disease (Koistinaho and Koistinaho, 2002), and there is increasing evidence that p38 MAPK inhibitors can protect against microglia-induced neurotoxicity in vivo (Barone et al, 2001;Koistinaho and Koistinaho, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Activation of p38 MAP kinase in microglia is an important upstream regulator of production of numerous potential neurotoxins, including proinflammatory cytokines and reactive nitrogen species (Jeohn et al, 2002;Koistinaho and Koistinaho, 2002). Hence, we assessed whether the neuroprotective effect of Kv1.3 channel blockers is through interference with p38 MAPK phosphorylation and consequent activation.…”
Section: P38 Mapk Activation and Microglia-mediated Neuron Killingmentioning
confidence: 99%
“…The p38 inhibitor SB203580 does not inhibit the phosphorylation of p38 but rather binds to the ATP pocket in the enzyme, thereby inhibiting its activity (Koistinaho and Koistinaho, 2002). On the other hand, FR167653 was first discovered as a potent inhibitor of tumor necrosis factor (TNF)-␣ and interleukin-1␤ production (Yamamoto et al, 1996(Yamamoto et al, , 1997.…”
Section: Inhibition Of P38 Activation Attenuates L5 Snl-induced Thermmentioning
confidence: 99%